UChicago Annual Updates from ASH 2019
S

Inherited Predisposition to Myeloid Hematologic Malignancies: Why Does Identification of Germline Predisposition Syndromes Matter?

By UChicago Annual Updates from ASH 2019 FEATURING Simone Feurstein
By UChicago Annual Updates from ASH 2019 FEATURING Simone Feurstein
53 views
March 20, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

12:23
Hematology Content

An ITP Case Study of Treating a Patient Who Was Non-responsive to St…

Feat. J. Bussel

Featured Video

17:01
Hematology Content

Q&A: Panel Discussion of a Treatment Option for ITP

Feat. T. Gernsheimer, J. Bussel, L. Tolba

Related Videos

Indy Hematology Review

22nd Annual Indy Hematology Review

Sat, Mar 8, 2025
SOHO Turkey 2025

12th SOHO Turkey Meeting

Sat, May 17, 2025
Total Health

West Oncology Conference

Sat, Feb 8, 2025
21:05

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Louisville Hematology Highlights

R. Gale

3.6K views
27:49

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Insights from 2024 EHA Annual Meeting

T. Badar

742 views
25:44

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

283 views
17:16

New

ASH 2024 Summary: Highlights in Bone Marrow Failure Disorders

2024 ASH Annual Meeting Insights Hub

P. Scheinberg

145 views
25:03

New

ASH 2024 Summary: Highlights in AML, MDS, and ALL

2024 ASH Annual Meeting Insights Hub

T. Badar

235 views
14:32

Summary of Recent Updates in MDS

Vanderbilt University Medical Center (VUMC)

S. Ball

447 views
22:37

AML and MDS Highlights & Key Takeaways

Insights from 2023 ASH Annual Meeting

T. Badar

2.2K views
23:04

Differentiation of CHIP, ICUS, CCUS, MDS, and VEXAS Syndrome

MyCancerHaven

R. Vij, S. Abedin

257 views
07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal
15:16

New

ASH 2024 Summary: Transplant Options and Outcomes for TP53 Myeloid D…

2024 ASH Annual Meeting Insights Hub

H. Fernandez

128 views
31:53

HSCT in 2024: What Every Hematologist Needs to Know

Indy Hematology Review

R. Childs

766 views
15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal
16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
24:44

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

921 views
45:10

Recent Advances in Classical Hematology

Indy Hematology Review

R. Brodsky

839 views
04:16

MDS and AML: Implementation of Guideline-Driven Germline Genetic Eva…

UChicago Medicine 12th International Clinical Cancer Genomics Conference

L. Banaszak

406 views
16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
20:58

New

Defining Risk of Progression in CHIP/CCUS: A Pathologists' Perspecti…

16th International Congress on Myeloproliferative Neoplasms

R. Hasserjian

94 views
23:37

Management of Viral Infections Post-Transplant: CMV, EBV, and HHV-6

Rush University Medical Center

E. Bhaimia

345 views
18:44

Current and Emerging Treatment Approaches for Patients With AML or M…

University of Miami Sylvester Comprehensive Cancer Center

S. Venugopal

138 views
AUTOPLAY